López-Díaz de Cerio, AscensiónPérez Estenaga, IñigoInoges, SusanaAbizanda, GloriaGavira, Juan JoséLarequi, EduardoAndreu, EnriqueRodríguez, SarayGil, Ana GloriaCrisostomo, VerónicaSánchez Margallo, F. M.Bermejo Thomas, Francisco JavierJauregui, BlancaQuintana, LluisFernández-Avilés Díaz, Francisco JesúsPelacho, BeatrizPrósper, Felipe2023-06-172023-06-172021López-Díaz De Cerio, A., Pérez Estenaga, I., Inoges, S. et al. «Preclinical Evaluation of the Safety and Immunological Action of Allogeneic ADSC-Collagen Scaffolds in the Treatment of Chronic Ischemic Cardiomyopathy». Pharmaceutics, vol. 13, n.o 8, agosto de 2021, p. 1269. DOI.org (Crossref), https://doi.org/10.3390/pharmaceutics13081269.1999-492310.3390/pharmaceutics13081269https://hdl.handle.net/20.500.14352/7076engAtribución 3.0 Españahttps://creativecommons.org/licenses/by/3.0/es/Preclinical Evaluation of the Safety and Immunological Action of Allogeneic ADSC-Collagen Scaffolds in the Treatment of Chronic Ischemic Cardiomyopathyjournal articlehttps://doi.org/10.3390/pharmaceutics13081269https://www.mdpi.com/journal/pharmaceuticsopen access615.4616.12-085Myocardial infarctionAdipose-derived mesenchymal stromal cellsCollagen scaffoldSafetyAllogeneicCardiologíaTecnología farmaceútica3205.01 Cardiología